Onconic Therapeutics - PE Ratio

The PE Ratio as of August 2026 (TTM) for Onconic Therapeutics (476060.KQ) is 45.79

According to Onconic Therapeutics’s latest financial reports and current stock price. The company's current PE Ratio is 45.79. This represents a change of 31.73% compared to the average of 34.76 of the last 4 quarters.

Onconic Therapeutics (476060.KQ) Historical PE Ratio (quarterly & annually)

How has 476060.KQ PE Ratio performed in the past?

The mean historical PE Ratio of Onconic Therapeutics over the last ten years is 19.22. The current 45.79 PE Ratio has changed 23.72% with respect to the historical average. Over the past ten years (40 quarters), 476060.KQ's PE Ratio was at its highest in in the March 2025 quarter at 150.00. The PE Ratio was at its lowest in in the June 2025 quarter at -375.00.

Onconic Therapeutics (476060.KQ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Onconic Therapeutics PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Onconic Therapeutics (476060.KQ) Average PE Ratio

How has 476060.KQ PE Ratio performed in the past?

The current PE Ratio of Onconic Therapeutics (476060.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Onconic Therapeutics (476060.KQ) PE Ratio vs. Peers

How is 476060.KQ’s PE Ratio compared to its peers?

Onconic Therapeutics’s PE Ratio is greater than Macrogen, Inc. (13.16), greater than MedPacto, Inc. (-6.18), greater than Amicogen, Inc. (-3.22), greater than GeneOne Life Science, Inc. (-0.23), greater than IMBdx (-5.04), greater than EASY BIO,Inc. (6.10), greater than Encell Co. Ltd. (-3.72), less than GC Genome Corporation (0), less than CG Invites Co., Ltd. (181.00), greater than HANDOK Inc. (-26.14),

Build a custom stock screener for Onconic Therapeutics (476060.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconic Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Onconic Therapeutics (476060.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Onconic Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.